Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

Phase 3Not Yet RecruitingNCT04345406

Tanta University60 enrolled

Overview

ACEIs as treatment for COVID19

ACEIs as suggested treatment for COVID19

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Captopril or enalapril

alexoquine

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients infected with covid 19 Exclusion Criteria: * allergy or contraindications to the drug

Tanta University

Tanta, Egypt

number of patients with virological cure

Time frame: 6 months

Sherief Abd-Elsalam

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.